Adipokines in gestational diabetes

The Lancet Diabetes and Endocrinology

Volumn 2, Issue 6, 2014, Pages 488-499

  Fasshauer, Mathias ^a   Blüher, Matthias ^a   Stumvoll, Michael ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; APELIN; AZGP1 PROTEIN; CHEMERIN; FATTY ACID BINDING PROTEIN 4; FIBROBLAST GROWTH FACTOR 21; LEPTIN; MESSENGER RNA; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; OMENTIN; PROGRANULIN; REGULATOR PROTEIN; RESISTIN; RETINOL BINDING PROTEIN 4; SERPINA12 PROTEIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; FABP4 PROTEIN, HUMAN; FATTY ACID BINDING PROTEIN; GLUCOSE BLOOD LEVEL;

CYTOKINE PRODUCTION; DISEASE ACTIVITY; DISEASE MARKER; DOWN REGULATION; HUMAN; INSULIN SENSITIVITY; MOLECULAR DYNAMICS; MOLECULAR PATHOLOGY; NONHUMAN; PREDICTION; PREGNANCY DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; RISK ASSESSMENT; RISK FACTOR; UPREGULATION; BLOOD; FEMALE; GLUCOSE BLOOD LEVEL; INSULIN RESISTANCE; METABOLISM; PREGNANCY;

ADIPOKINES; ADIPONECTIN; BLOOD GLUCOSE; DIABETES, GESTATIONAL; FATTY ACID-BINDING PROTEINS; FEMALE; HUMANS; INSULIN RESISTANCE; LEPTIN; PREGNANCY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84901620845     PISSN: 22138587     EISSN: 22138595     Source Type: Journal    
DOI: 10.1016/S2213-8587(13)70176-1     Document Type: Review

References (105)

1. Landon MB, Gabbe SG Gestational diabetes mellitus. Obstet Gynecol 2011, 118:1379-1393.
2. Vrachnis N, Augoulea A, Iliodromiti Z, Lambrinoudaki I, Sifakis S, Creatsas G Previous gestational diabetes mellitus and markers of cardiovascular risk. Int J Endocrinol 2012, 2012:458610.
3. Lambrinoudaki I, Vlachou SA, Creatsas G Genetics in gestational diabetes mellitus: association with incidence, severity, pregnancy outcome and response to treatment. Curr Diabetes Rev 2010, 6:393-399.
4. Kralisch S, Bluher M, Paschke R, Stumvoll M, Fasshauer M Adipokines and adipocyte targets in the future management of obesity and the metabolic syndrome. Mini Rev Med Chem 2007, 7:39-45.
5. Festa A, Shnawa N, Krugluger W, Hopmeier P, Schernthaner G, Haffner SM Relative hypoleptinaemia in women with mild gestational diabetes mellitus. Diabet Med 1999, 16:656-662.
6. Mokhtari M, Hashemi M, Yaghmaei M, Naderi M, Shikhzadeh A, Ghavami S Evaluation of the serum leptin in normal pregnancy and gestational diabetes mellitus in Zahedan, southeast Iran. Arch Gynecol Obstet 2011, 284:539-542.
7. Horosz E, Bomba-Opon DA, Szymanska M, Wielgos M Third trimester plasma adiponectin and leptin in gestational diabetes and normal pregnancies. Diabetes Res Clin Pract 2011, 93:350-356.
8. Saucedo R, Zarate A, Basurto L, et al. Relationship between circulating adipokines and insulin resistance during pregnancy and postpartum in women with gestational diabetes. Arch Med Res 2011, 42:318-323.
9. Skvarca A, Tomazic M, Krhin B, Blagus R, Janez A Adipocytokines and insulin resistance across various degrees of glucose tolerance in pregnancy. J Int Med Res 2012, 40:583-589.
10. Maple-Brown L, Ye C, Hanley AJ, et al. Maternal pregravid weight is the primary determinant of serum leptin and its metabolic associations in pregnancy, irrespective of gestational glucose tolerance status. J Clin Endocrinol Metab 2012, 97:4148-4155.
11. Ranheim T, Haugen F, Staff AC, Braekke K, Harsem NK, Drevon CA Adiponectin is reduced in gestational diabetes mellitus in normal weight women. Acta Obstet Gynecol Scand 2004, 83:341-347.
12. Thyfault JP, Hedberg EM, Anchan RM, et al. Gestational diabetes is associated with depressed adiponectin levels. J Soc Gynecol Investig 2005, 12:41-45.
13. Retnakaran R, Qi Y, Connelly PW, Sermer M, Hanley AJ, Zinman B Low adiponectin concentration during pregnancy predicts postpartum insulin resistance, beta cell dysfunction and fasting glycaemia. Diabetologia 2010, 53:268-276.
14. Ortega-Senovilla H, Schaefer-Graf U, Meitzner K, et al. Gestational diabetes mellitus causes changes in the concentrations of adipocyte fatty acid-binding protein and other adipocytokines in cord blood. Diabetes Care 2011, 34:2061-2066.
15. Lappas M, Yee K, Permezel M, Rice GE Release and regulation of leptin, resistin and adiponectin from human placenta, fetal membranes, and maternal adipose tissue and skeletal muscle from normal and gestational diabetes mellitus-complicated pregnancies. J Endocrinol 2005, 186:457-465.
16. Tepper BJ, Kim Y-K, Shete V, Shabrova E, Quadro L Serum retinol-binding protein 4 (RBP4) and retinol in a cohort of borderline obese women with and without gestational diabetes. Clin Biochem 2010, 43:320-323.
17. Park S, Kim M-Y, Baik SH, et al. Gestational diabetes is associated with high energy and saturated fat intakes and with low plasma visfatin and adiponectin levels independent of prepregnancy BMI. Eur J Clin Nutr 2013, 67:196-201.
18. Stepan H, Kralisch S, Klostermann K, et al. Preliminary report: circulating levels of the adipokine vaspin in gestational diabetes mellitus and preeclampsia. Metabolism 2010, 59:1054-1056.
19. Vitoratos N, Salamalekis E, Kassanos D, et al. Maternal plasma leptin levels and their relationship to insulin and glucose in gestational-onset diabetes. Gynecol Obstet Invest 2001, 51:17-21.
20. Kautzky-Willer A, Pacini G, Tura A, et al. Increased plasma leptin in gestational diabetes. Diabetologia 2001, 44:164-172.
21. Buhling KJ, Harder T, Sehouli J, Nanz J, Plagemann A, Dudenhausen JW Independent association between leptin and blood pressure during third trimester in normal and gestational diabetic pregnancies. Eur J Obstet Gynecol Reprod Biol 2005, 119:180-184.
22. Atègbo J-M, Grissa O, Yessoufou A, et al. Modulation of adipokines and cytokines in gestational diabetes and macrosomia. J Clin Endocrinol Metab 2006, 91:4137-4143.
23. Gao XL, Yang HX, Zhao Y Variations of tumor necrosis factor-alpha, leptin and adiponectin in mid-trimester of gestational diabetes mellitus. Chin Med J (Engl) 2008, 121:701-705.
24. Yilmaz O, Kucuk M, Ilgin A, Dagdelen M Assessment of insulin sensitivity/resistance and their relations with leptin concentrations and anthropometric measures in a pregnant population with and without gestational diabetes mellitus. J Diabetes Complications 2010, 24:109-114.
25. Chen D, Xia G, Xu P, Dong M Peripartum serum leptin and soluble leptin receptor levels in women with gestational diabetes. Acta Obstet Gynecol Scand 2010, 89:1595-1599.
26. Soheilykhah S, Mojibian M, Rahimi-Saghand S, Rashidi M, Hadinedoushan H Maternal serum leptin concentration in gestational diabetes. Taiwan J Obstet Gynecol 2011, 50:149-153.
27. López-Tinoco C, Roca M, Fernández-Deudero A, et al. Cytokine profile, metabolic syndrome and cardiovascular disease risk in women with late-onset gestational diabetes mellitus. Cytokine 2012, 58:14-19.
28. Palik E, Baranyi E, Melczer Z, et al. Elevated serum acylated (biologically active) ghrelin and resistin levels associate with pregnancy-induced weight gain and insulin resistance. Diabetes Res Clin Pract 2007, 76:351-357.
29. McLachlan KA, O'Neal D, Jenkins A, Alford FP Do adiponectin, TNFalpha, leptin and CRP relate to insulin resistance in pregnancy? Studies in women with and without gestational diabetes, during and after pregnancy. Diabetes Metab Res Rev 2006, 22:131-138.
30. Retnakaran R, Hanley AJG, Raif N, Connelly PW, Sermer M, Zinman B Reduced adiponectin concentration in women with gestational diabetes: a potential factor in progression to type 2 diabetes. Diabetes Care 2004, 27:799-800.
31. Retnakaran R, Hanley AJ, Raif N, et al. Adiponectin and beta cell dysfunction in gestational diabetes: pathophysiological implications. Diabetologia 2005, 48:993-1001.
32. Worda C, Leipold H, Gruber C, Kautzky-Willer A, Knöfler M, Bancher-Todesca D Decreased plasma adiponectin concentrations in women with gestational diabetes mellitus. Am J Obstet Gynecol 2004, 191:2120-2124.
33. Kinalski M, Telejko B, Kuźmicki M, Kretowski A, Kinalska I Tumor necrosis factor alpha system and plasma adiponectin concentration in women with gestational diabetes. Horm Metab Res 2005, 37:450-454.
34. Tsai P-J, Yu C-H, Hsu S-P, et al. Maternal plasma adiponectin concentrations at 24 to 31 weeks of gestation: negative association with gestational diabetes mellitus. Nutrition 2005, 21:1095-1099.
35. Cortelazzi D, Corbetta S, Ronzoni S, et al. Maternal and foetal resistin and adiponectin concentrations in normal and complicated pregnancies. Clin Endocrinol (Oxf) 2007, 66:447-453.
36. Altinova AE, Toruner F, Bozkurt N, et al. Circulating concentrations of adiponectin and tumor necrosis factor-α in gestational diabetes mellitus. Gynecol Endocrinol 2007, 23:161-165.
37. Vitoratos N, Deliveliotou A, Vlahos NF, et al. Serum adiponectin during pregnancy and postpartum in women with gestational diabetes and normal controls. Gynecol Endocrinol 2008, 24:614-619.
38. Soheilykhah S, Mohammadi M, Mojibian M, et al. Maternal serum adiponectin concentration in gestational diabetes. Gynecol Endocrinol 2009, 25:593-596.
39. Ballesteros M, Simón I, Vendrell J, et al. Maternal and cord blood adiponectin multimeric forms in gestational diabetes mellitus: a prospective analysis. Diabetes Care 2011, 34:2418-2423.
40. Matuszek B, Burska A, Leszczyńska-Gorzelak B, Donica H, Nowakowski A Comparative analysis of adiponectin isoform distribution in pregnant women with gestational diabetes mellitus and after delivery. Acta Obstet Gynecol Scand 2013, 92:951-959.
41. Näf S, Escote X, Yañez RE, et al. Zinc-α2-glycoprotein is unrelated to gestational diabetes: anthropometric and metabolic determinants in pregnant women and their offspring. PLoS One 2012, 7:e47601.
42. Mazaki-Tovi S, Romero R, Vaisbuch E, et al. Maternal serum adiponectin multimers in gestational diabetes. J Perinat Med 2009, 37:637-650.
43. Ma Y, Cheng Y, Wang J, Cheng H, Zhou S, Li X The changes of visfatin in serum and its expression in fat and placental tissue in pregnant women with gestational diabetes. Diabetes Res Clin Pract 2010, 90:60-65.
44. Salmi AA, Zaki NM, Zakaria R, Nor Aliza AG, Rasool AH Arterial stiffness, inflammatory and pro-atherogenic markers in gestational diabetes mellitus. Vasa 2012, 41:96-104.
45. Kralisch S, Stepan H, Kratzsch J, et al. Serum levels of adipocyte fatty acid binding protein are increased in gestational diabetes mellitus. Eur J Endocrinol 2009, 160:33-38.
46. Qiu C, Williams MA, Vadachkoria S, Frederick IO, Luthy DA Increased maternal plasma leptin in early pregnancy and risk of gestational diabetes mellitus. Obstet Gynecol 2004, 103:519-525.
47. Georgiou HM, Lappas M, Georgiou GM, et al. Screening for biomarkers predictive of gestational diabetes mellitus. Acta Diabetol 2008, 45:157-165.
48. Williams MA, Qiu C, Muy-Rivera M, Vadachkoria S, Song T, Luthy DA Plasma adiponectin concentrations in early pregnancy and subsequent risk of gestational diabetes mellitus. J Clin Endocrinol Metab 2004, 89:2306-2311.
49. Lain KY, Daftary AR, Ness RB, Roberts JM First trimester adipocytokine concentrations and risk of developing gestational diabetes later in pregnancy. Clin Endocrinol (Oxf) 2008, 69:407-411.
50. Ferreira AFA, Rezende JC, Vaikousi E, Akolekar R, Nicolaides KH Maternal serum visfatin at 11-13 weeks of gestation in gestational diabetes mellitus. Clin Chem 2011, 57:609-613.
51. Lacroix M, Battista M-C, Doyon M, et al. Lower adiponectin levels at first trimester of pregnancy are associated with increased insulin resistance and higher risk of developing gestational diabetes mellitus. Diabetes Care 2013, 36:1577-1583.
52. Weerakiet S, Lertnarkorn K, Panburana P, Pitakitronakorn S, Vesathada K, Wansumrith S Can adiponectin predict gestational diabetes?. Gynecol Endocrinol 2006, 22:362-368.
53. Paradisi G, Ianniello F, Tomei C, et al. Longitudinal changes of adiponectin, carbohydrate and lipid metabolism in pregnant women at high risk for gestational diabetes. Gynecol Endocrinol 2010, 26:539-545.
54. Abetew DF, Qiu C, Fida NG, et al. Association of retinol binding protein 4 with risk of gestational diabetes. Diabetes Res Clin Pract 2013, 99:48-53.
55. Nanda S, Nikoletakis G, Markova D, Poon LCY, Nicolaides KH Maternal serum retinol-binding protein-4 at 11-13 weeks' gestation in normal and pathological pregnancies. Metabolism 2013, 62:814-819.
56. Nanda S, Poon LCY, Muhaisen M, Acosta IC, Nicolaides KH Maternal serum resistin at 11 to 13 weeks' gestation in normal and pathological pregnancies. Metabolism 2012, 61:699-705.
57. D'Anna R, Baviera G, Corrado F, Giordano D, Recupero S, Di Benedetto A First trimester serum neutrophil gelatinase-associated lipocalin in gestational diabetes. Diabet Med 2009, 26:1293-1295.
58. Zhou Y, Rui L Leptin signaling and leptin resistance. Fr Medecine 2013, 7:207-222.
59. Pérez-Pérez A, Maymó JL, Gambino YP, et al. Activated translation signaling in placenta from pregnant women with gestational diabetes mellitus: possible role of leptin. Horm Metab Res 2013, 45:436-442.
60. Meller M, Qiu C, Vadachkoria S, Abetew DF, Luthy DA, Williams MA Changes in placental adipocytokine gene expression associated with gestational diabetes mellitus. Physiol Res 2006, 55:501-512.
61. Uzelac PS, Li X, Lin J, et al. Dysregulation of leptin and testosterone production and their receptor expression in the human placenta with gestational diabetes mellitus. Placenta 2010, 31:581-588.
62. Kleiblova P, Dostalova I, Bartlova M, et al. Expression of adipokines and estrogen receptors in adipose tissue and placenta of patients with gestational diabetes mellitus. Mol Cell Endocrinol 2010, 314:150-156.
63. Kuzmicki M, Telejko B, Wawrusiewicz-Kurylonek N, et al. The expression of suppressor of cytokine signaling 1 and 3 in fat and placental tissue from women with gestational diabetes. Gynecol Endocrinol 2012, 28:841-844.
64. Alonso A, Del Rey CG, Navarro A, Tolivia J, González CG Effects of gestational diabetes mellitus on proteins implicated in insulin signaling in human placenta. Gynecol Endocrinol 2006, 22:526-535.
65. Yamashita H, Shao J, Ishizuka T, et al. Leptin administration prevents spontaneous gestational diabetes in heterozygous Lepr(db/+) mice: effects on placental leptin and fetal growth. Endocrinology 2001, 142:2888-2897.
66. Kishida K, Funahashi T, Shimomura I Molecular mechanisms of diabetes and atherosclerosis: role of adiponectin. Endocr Metab Immune Disord Drug Targets 2012, 12:118-131.
67. Chen J, Tan B, Karteris E, et al. Secretion of adiponectin by human placenta: differential modulation of adiponectin and its receptors by cytokines. Diabetologia 2006, 49:1292-1302.
68. Aye ILMH, Powell TL, Jansson T Review: adiponectin-the missing link between maternal adiposity, placental transport and fetal growth?. Placenta 2013, 34(suppl):S40-S45.
69. Bouchard L, Hivert M-F, Guay S-P, St-Pierre J, Perron P, Brisson D Placental adiponectin gene DNA methylation levels are associated with mothers' blood glucose concentration. Diabetes 2012, 61:1272-1280.
70. Dunmore SJ, Brown JEP The role of adipokines in β-cell failure of type 2 diabetes. J Endocrinol 2013, 216:T37-T45.
71. Cawthorn WP, Sethi JK TNF-alpha and adipocyte biology. FEBS Lett 2008, 582:117-131.
72. Kirwan JP, Hauguel-De Mouzon S, Lepercq J, et al. TNF-α is a predictor of insulin resistance in human pregnancy. Diabetes 2002, 51:2207-2213.
73. Bobadilla RA, van Bree R, Vercruysse L, Pijnenborg R, Verhaeghe J Placental effects of systemic tumour necrosis factor-α in an animal model of gestational diabetes mellitus. Placenta 2010, 31:1057-1063.
74. Heinig J, Wilhelm S, Müller H, Briese V, Bittorf T, Brock J Determination of cytokine mRNA-expression in term human placenta of patients with gestational hypertension, intrauterine growth retardation and gestational diabetes mellitus using polymerase chain reaction. Zentralbl Gynakol 2000, 122:413-418.
75. Radaelli T, Varastehpour A, Catalano P, Hauguel-de Mouzon S Gestational diabetes induces placental genes for chronic stress and inflammatory pathways. Diabetes 2003, 52:2951-2958.
76. Kralisch S, Fasshauer M Adipocyte fatty acid binding protein: a novel adipokine involved in the pathogenesis of metabolic and vascular disease?. Diabetologia 2013, 56:10-21.
77. Biron-Shental T, Schaiff WT, Ratajczak CK, Bildirici I, Nelson DM, Sadovsky Y Hypoxia regulates the expression of fatty acid-binding proteins in primary term human trophoblasts. Am J Obstet Gynecol 2007, 197:516.e1-516.e6.
78. Scifres CM, Chen B, Nelson DM, Sadovsky Y Fatty acid binding protein 4 regulates intracellular lipid accumulation in human trophoblasts. J Clin Endocrinol Metab 2011, 96:E1083-E1091.
79. Kotnik P, Fischer-Posovszky P, Wabitsch M RBP4: a controversial adipokine. Eur J Endocrinol 2011, 165:703-711.
80. Kuzmicki M, Telejko B, Wawrusiewicz-Kurylonek N, et al. Retinol-binding protein 4 in adipose and placental tissue of women with gestational diabetes. Gynecol Endocrinol 2011, 27:1065-1069.
81. Jamaluddin MS, Weakley SM, Yao Q, Chen C Resistin: functional roles and therapeutic considerations for cardiovascular disease. Br J Pharmacol 2012, 165:622-632.
82. Yura S, Sagawa N, Itoh H, et al. Resistin is expressed in the human placenta. J Clin Endocrinol Metab 2003, 88:1394-1397.
83. Chang Y-H, Chang D-M, Lin K-C, Shin S-J, Lee Y-J Visfatin in overweight/obesity, type 2 diabetes mellitus, insulin resistance, metabolic syndrome and cardiovascular diseases: a meta-analysis and systemic review. Diabetes Metab Res Rev 2011, 27:515-527.
84. Telejko B, Kuzmicki M, Zonenberg A, et al. Visfatin in gestational diabetes: serum level and mRNA expression in fat and placental tissue. Diabetes Res Clin Pract 2009, 84:68-75.
85. Ognjanovic S, Tashima LS, Bryant-Greenwood GD The effects of pre-B-cell colony-enhancing factor on the human fetal membranes by microarray analysis. Am J Obstet Gynecol 2003, 189:1187-1195.
86. Blüher M Vaspin in obesity and diabetes: pathophysiological and clinical significance. Endocrine 2012, 41:176-182.
87. Caminos JE, Bravo SB, Garcés MF, et al. Vaspin and amylin are expressed in human and rat placenta and regulated by nutritional status. Histol Histopathol 2009, 24:979-990.
88. Gkiomisi A, Makedou KG, Anastasilakis AD, et al. Serum vaspin levels in women with and without gestational diabetes mellitus during pregnancy and postpartum. Cytokine 2013, 61:127-132.
89. Roman AA, Parlee SD, Sinal CJ Chemerin: a potential endocrine link between obesity and type 2 diabetes. Endocrine 2012, 42:243-251.
90. van Poppel MNM, Zeck W, Ulrich D, et al. Cord blood chemerin: differential effects of gestational diabetes mellitus and maternal obesity. Clin Endocrinol (Oxf) 2013, 80:65-72.
91. Barker G, Lim R, Rice GE, Lappas M Increased chemerin concentrations in fetuses of obese mothers and correlation with maternal insulin sensitivity. J Matern Fetal Neonatal Med 2012, 25:2274-2280.
92. Nguyen AD, Nguyen TA, Martens LH, Mitic LL, Farese RV Progranulin: at the interface of neurodegenerative and metabolic diseases. Trends Endocrinol Metab 2013, published online Sept 10. 10.1016/j.tem.2013.08.003.
93. Stubert J, Richter D-U, Gerber B, Briese V Expression pattern of progranulin in the human placenta and its effect on cell proliferation in the choriocarcinoma cell line BeWo. J Reprod Dev 2011, 57:229-235.
94. Iglesias P, Selgas R, Romero S, Díez JJ Biological role, clinical significance, and therapeutic possibilities of the recently discovered metabolic hormone fibroblastic growth factor 21. Eur J Endocrinol 2012, 167:301-309.
95. Meissburger B, Stachorski L, Röder E, Rudofsky G, Wolfrum C Tissue inhibitor of matrix metalloproteinase 1 (TIMP1) controls adipogenesis in obesity in mice and in humans. Diabetologia 2011, 54:1468-1479.
96. Niu R, Okamoto T, Iwase K, Nomura S, Mizutani S Quantitative analysis of matrix metalloproteinases-2 and -9, and their tissue inhibitors-1 and -2 in human placenta throughout gestation. Life Sci 2000, 66:1127-1137.
97. Jang Y, Lee JH, Wang Y, Sweeney G Emerging clinical and experimental evidence for the role of lipocalin-2 in metabolic syndrome. Clin Exp Pharmacol Physiol 2012, 39:194-199.
98. Tadesse S, Luo G, Park JS, et al. Intra-amniotic infection upregulates neutrophil gelatinase-associated lipocalin (NGAL) expression at the maternal-fetal interface at term: implications for infection-related preterm birth. Reprod Sci 2011, 18:713-722.
99. Bing C, Mracek T, Gao D, Trayhurn P Zinc-α2-glycoprotein: an adipokine modulator of body fat mass. Int J Obes (Lond) 2010, 34:1559-1565.
100. Castan-Laurell I, Dray C, Attané C, Duparc T, Knauf C, Valet P Apelin, diabetes, and obesity. Endocrine 2011, 40:1-9.
101. Telejko B, Kuzmicki M, Wawrusiewicz-Kurylonek N, et al. Plasma apelin levels and apelin/APJ mRNA expression in patients with gestational diabetes mellitus. Diabetes Res Clin Pract 2010, 87:176-183.
102. Tan BK, Adya R, Randeva HS Omentin: a novel link between inflammation, diabesity, and cardiovascular disease. Trends Cardiovasc Med 2010, 20:143-148.
103. Barker G, Lim R, Georgiou HM, Lappas M Omentin-1 is decreased in maternal plasma, placenta and adipose tissue of women with pre-existing obesity. PLoS One 2012, 7:e42943.
104. Körner A, Garten A, Blüher M, Tauscher R, Kratzsch J, Kiess W Molecular characteristics of serum visfatin and differential detection by immunoassays. J Clin Endocrinol Metab 2007, 92:4783-4791.
105. Ouchi N, Parker JL, Lugus JJ, Walsh K Adipokines in inflammation and metabolic disease. Nat Rev Immunol 2011, 11:85-97.